Format

Send to

Choose Destination
Eur J Cell Biol. 2014 Jan-Feb;93(1-2):11-22. doi: 10.1016/j.ejcb.2014.02.001. Epub 2014 Feb 11.

The role of microRNAs in melanoma.

Author information

1
Translational Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Electronic address: c.luo@dkfz.de.
2
Translational Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
3
Institute of Pathology, University of Regensburg, 93053 Regensburg, Germany.
4
Translational Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Electronic address: s.eichmueller@dkfz.de.

Abstract

Melanoma is the most dangerous form of skin cancer, being largely resistant to conventional therapies at advanced stages. Understanding the molecular mechanisms behind this disease might be the key for the development of novel therapeutic strategies. MicroRNAs (miRNAs) are small non-coding RNAs that post-transcriptionally control gene expression, thereby regulating various cellular signaling pathways involved in the initiation and progression of different cancer types, including melanoma. In this review, we summarize approaches for the identification of candidate miRNAs and their target genes and review the functions of miRNAs in melanoma. Finally, we highlight the recent progress in pre-clinical use of miRNAs as prognostic markers and therapeutic targets.

KEYWORDS:

Bioinformatics; Diagnosis; Expression profiling; Melanoma; MicroRNA; Oncogene; Target identification; Therapy; Tumor marker; Tumor suppressor

PMID:
24602414
DOI:
10.1016/j.ejcb.2014.02.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center